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Introduction
Human tuberculosis is a pandemic disease in many parts
of the world causing approximately 2 million deaths
annually. It is estimated that one-third of the world pop-
ulation is infected with Mycobacterium tuberculosis, the
main cause of the disease (World Health Organization –
Tuberculosis Fact Sheet Number 104). bacillus Cal-
mette–Gue´rin (BCG) is the only approved vaccine against
tuberculosis. It was developed through serial in vitro pas-
sages of Mycobacterium bovis until it was non-pathogenic.
Although it has been effective against development of
tuberculosis in some countries such as the United King-
dom [1], its efficacy has been questioned in several other
studies, most notably in India, where very limited pro-
tection has been reported [2].
Even though BCG vaccine is safe and rarely induces
disease in humans, BCG seems to mimic its own virulent
strain and has the ability to inhibit antigen processing
and presentation to T cells [3–5]. Macrophages infected
with M. tuberculosis or BCG present low levels of major
histocompatibility complex class II (MHC-II) [6, 7]; this
process is primarily dependent on IL-10 production
induced by mycobacteria [8]. Corroborating with these
studies, it was verified that dendritic cells exposed to
BCG were able to induce naive T cell differentiation to
IL-10 producer T cells. These observations indicate a pos-
sible contribution of BCG in preventing an immune
response [9], and promoting mycobacterial survival.
Reactive oxygen species (ROS) are produced by the
NADPH oxidase system to combat invading microorgan-
isms in host tissue [10]. Some pathogens can break the
burst oxidative after their phagocytosis and evade the
immune response. For example, the Francisella tularensis
live vaccine strain was able to prevent the NADPH sys-
tem assembly in human neutrophil phagosome, which
permits its escape to cytosol and survival [11]. Like the
F. tularensis vaccine, BCG and virulent mycobacterium
strains can evade the immune system. BCG can prevent
its death by inhibiting the phagosome–lysosome fusion
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Abstract
We investigated the effects of viable, extended freeze-drying (EFD) or heat-
killed (HK) Mycobacterium bovis bacillus Calmette–Gue´rin (BCG) in respiratory
burst activity, gene expression of CYBB and NCF1 encoding components of
the human phagocyte nicotinamide adenine dinucleotide (NADPH) oxidase,
TLR2 expression, and in IL-10 and TNF-a cytokine production by human
peripheral blood mononuclear cells (PBMCs). Viable BCG significantly inhib-
ited TLR2 and CYBB gene expression, as well as superoxide release by human
PBMC. All BCG stimuli augmented IL-10 release, but only HK BCG or via-
ble BCG increased TNF-a release by PBMCs. Our studies show that viable
BCG can impair the NADPH oxidase system activation and the TLR2 route
in human PBMCs. As well, different BCG preparations can distinctly influence
cytokine production by human PBMCs.
B A S I C IMMUNO LOG Y doi: 10.1111/j.1365-3083.2011.02632.x
..................................................................................................................................................................
 2011 The Authors
96 Scandinavian Journal of Immunology  2011 Blackwell Publishing Ltd. Scandinavian Journal of Immunology 75, 96–101
acting on tryptophane aspartate-containing coat protein
(TACO protein) in animal models or over its analogue
protein, the coronin-1 in human leucocytes [12, 13].
Nevertheless, it is not known whether BCG has a direct
effect on the NADPH oxidase system.
Toll-like receptor 2 (TLR2) is involved in the recogni-
tion of mycobacteria and their purified components [4,
14]. The activation of TLR2 may trigger the expression
of several genes through a complex signalization network
[15]. Tuberculin PPD stimulation results in rapid activa-
tion of mitogen-activated protein kinases (MAPKs) and
an early burst of ROS in monocytes ⁄macrophages in a
TLR2-dependent manner [16]. In addition, ROS are
involved in modulating diverse receptor–ligand intracel-
lular signalling pathways, including MAPK and nuclear
factor-kB pathways [17–19].
Given the lack of data about the possible effects of
viable BCG vaccine on the NADPH oxidase system and
the TLR2 leucocyte activation route, the aim of the pres-
ent work was to investigate the NADPH activation and
the gene expression of TLR2 in human peripheral blood
mononuclear cell (PBMC). We also verified the IL-10
and TNF-a cytokine production and compared the two
inactive BCG preparations, extended freeze-dried (EFD)
and heat-killed (HK) BCG.
Materials and methods
Subjects. We collected blood samples from adult healthy
donors (n = 50) (mean age, 26.2 years ± 6.8) for the
PBMC assay. Informed consent was obtained from all
participants, and the study was approved by Institute of
Biomedical Sciences, University of Sao Paulo Ethics
Committee, according to the Helsinki Convention.
BCG preparations. The HK and live BCG were
obtained from Onco-BCG vaccine (Moreau strain, Copen-
hagen, seed # July 1978) developed by Butantan Insti-
tute (Sa˜o Paulo, Brazil) [20]. The EFD BCG (Pasteur
strain 1173P2) was prepared at Pasteur Institute (Paris,
France) as previously described [21, 22]. The HK BCG
was autoclaved for 30 min at 121 C in saline buffer. All
bacilli were washed with saline buffer before their incu-
bation with PBMC.
Cells and culture conditions. Venous blood samples
were collected into heparinized tubes, and Ficoll-
Hypaque (Sigma-Aldrich Histopaque 1.077 g ⁄ml; St.
Louis, MO, USA) was used for PBMC cell separation.
The PBMC were cultured in RPMI 1640 complete
medium supplemented with 10% heat-inactivated foetal
bovine serum and 2 mM L-glutamine at 37 C in a
humidified 5% CO2 atmosphere in 24-well plates, 5 ·
105 cells ⁄500 ll ⁄well for gene expression or 1 ·
106 cells ⁄ml ⁄well for superoxide release or cytokine
assays. The cells were incubated in the absence (control
group) or presence of live, HK or EFD BCG (at an MOI
of 20 BCG ⁄PBMC), the TLR-2 ⁄6 ligand FSL-1 (syn-
thetic diacylated lipopeptide FSL-1; Invivogen, San
Diego, CA, USA) (1 lg ⁄ml), or IFN-c (100 U ⁄ml) plus
TNF-a (1000 U ⁄ml) for 24 h. After incubation, 120 ll
supernatant was collected from the respective culture
wells and frozen at )80 C until cytokine analysis. The
PBMC viability was measured by trypan blue method at
the beginning and at the end of incubations.
Superoxide release. Superoxide release was assessed by a
superoxide dismutase-inhibitable cytochrome c reduction
assay, modified as previously described [23]. Briefly,
PBMC cells (1 · 106 cells ⁄ml ⁄well) were cultured in 24-
well plates for 24 h. On the day of the experiment, the
plates were centrifuged, the supernatant removed, and
the cells incubated in Hanks balanced salt solution (with-
out phenol red) containing cytochrome c (50 lM) and
phorbol myristate acetate (PMA; 300 nM) for 1 h at
37 C in a humidified 5% CO2 atmosphere. Half of the
wells received superoxide dismutase (50 U ⁄ml) at the
beginning of the incubation. PMA was used as an activa-
tor of superoxide release. After incubation, all plates were
placed on ice, and the remaining wells received superox-
ide dismutase. The plates were centrifuged again, and the
optical absorbance of the supernatants measured at
550 nm. The amount of superoxide released was calcu-
lated using an extinction coefficient of 0.021 ⁄nM ⁄ cm.
The results (nmol O2
) ⁄106 cells ⁄h) were expressed by
the difference of absorbance among samples that received
or not SOD at the beginning of assay. At the end of the
experiments, PBMC viability was assessed by trypan
blue.
RT-PCR. Total RNA was isolated from PBMC
(5 · 105 cells) by TRIzol (Invitrogen, Carlsbad, CA,
USA), according to manufacturer’s instructions. Reverse
transcription of 1 lg total RNA was performed with
SuperScript II RT and random hexamers. The cDNA was
amplified for standard PCR using the kit QuantumRNA
18S Internal Standards (Applied Biosystems ⁄Ambion,
Austin, TX, USA) to normalize the amount of template.
The following specific primers were used: gp91phox (Gen-
Bank NM_000397.3): forward, 5¢-GCT CTA GAG CAT
GAG GGG CTC TCC ATT TTT GTC A-3¢; reverse, 5¢-
CGG GAT CCC GAG TTC AGA GAG TGC TAC
TGA ATA A-3¢; p47phox (GenBank NM_000265.4): for-
ward, 5¢-GCG CTT CGT ACC CAG CCA GCA CTA
TGT-3¢; reverse, 5¢-CTG TCG CGG TAC TCT TGC
CAT CTT TGG C-3¢; and TLR2 (GenBank
NM_003264.3): forward, 5¢-CCT GGG CAG TCT TGA
ACA TT-3¢; reverse, 5¢-TTC CCA CTC TCA GGA TTT
GC-3¢. Cycle conditions for the ABI 5700 thermal cycler
were: 95 C for 2 min, followed by 30 cycles of denatur-
ation at 95 C for 15 s, melting at 63 C for 30 s, exten-
sion at 72 C for 45 s and a long extension at 72 C for
7 min. The band densitometry of samples in agarose gel
with ethidium bromide 1.5% was performed in Image-
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Master VDS System (Amersham Pharmacia ⁄GE Health-
care Biosciences, Pittsburgh, PA, USA). The reactions
were run in triplicate, and the results were represented as
mean plus or minus SD.
Cytokine ELISA. Cytokine concentrations were analy-
sed by ELISA, using IL-10 and TNF-a Duo Set kits
(R&D Systems Inc., Minneapolis, MN, USA), according
to the manufacturer’s instructions. Optical density was
determined using MR5000 ELISA reader (Thermolab
Systems, Ashford, UK). Cytokine amounts were deter-
mined by standard curve comparison. The results were
expressed in pg ⁄ml ⁄106 PBMC. The PBMC number was
carried out from blood cell counts on day 0.
Statistics. Results were expressed as box-plots: 25 and
75 percentiles, minimum and maximum, median and
mean values; or as scatter plots: data and median values.
Comparisons among groups were established by Mann–
Whitney or Kruskal–Wallis test followed by Dunn’s test.
P-values < 0.05 were considered significant.
Results
To test the effect of live, HK, or EFD BCG or TLR-2 ⁄6
ligand FSL-1 on the NADPH oxidase system, we first
studied the respiratory burst activity. As shown in
Fig. 1, the augment of superoxide release was observed
only by PBMC samples incubated with rhIFN-c and
rhTNF-a (P < 0.05), well-known NADPH oxidase acti-
vators [24]. Incubation of these cells with live BCG
resulted in marked reduction in superoxide release
(P < 0.05). In addition, a very significant difference
between live and EFD BCG in superoxide induction was
observed (P < 0.01). Live BCG was able to reduce in
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Figure 1 Phorbol myristate acetate (PMA)-stimulated superoxide
release by peripheral blood mononuclear cell. 1 · 106 cells ⁄ml were
incubated in the absence (control group – C) or presence of live, heat-
killed, extended freeze-drying bacillus Calmette–Gue´rin, FSL-1 or IFN-
c ⁄TNF-a for 24 h, followed by PMA stimulus (300 nM) for 1 h. The
results are shown as nmol O2
) ⁄ 106 cells ⁄ h. *Indicates P < 0.05,
Mann–Whitney test; + signs within the grey boxes represent the mean
values; ) signs within the grey boxes represent the median values,
n = 11.
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Figure 2 CYBB (Panel A), NCF1 (Panel B) and TLR2 (Panel C) gene
expression by peripheral blood mononuclear cell. 5 · 105 cells ⁄ml were
incubated in the absence (control group – C) or presence of live, heat-
killed, extended freeze-drying bacillus Calmette–Gue´rin, FSL-1 or IFN-
c ⁄TNF-a for 24 h. The results are shown as relative gene expression.
*Indicates P < 0.05, **indicates P < 0.01, Mann–Whitney test; +
signs within the grey boxes represent the mean values; ) signs within
the grey boxes represent the median values, n = at least 11.
98 Human Leucocytes Response to Live, EFD or HK BCG J. Moreira et al.
..................................................................................................................................................................
 2011 The Authors
Scandinavian Journal of Immunology  2011 Blackwell Publishing Ltd. Scandinavian Journal of Immunology 75, 96–101
69% the superoxide release induced by PMA. This
activity was expressed by live viable PBMC as assessed
by tripan blue count.
Investigating by which means the BCG had influenced
the NADPH oxidase activity, we analysed the gene
expression of CYBB and NCF1 which encode gp91phox
and p47phox, respectively, the two principal subunits of
this enzymatic system. As shown in Fig. 2A, live BCG
decreased CYBB gene expression (P < 0.05). FSL-1
increases CYBB transcripts (P < 0.05); however, this was
not associated with an increase in superoxide release. The
NCF1 expression was not affected by the different BCG
preparations or TLR-2 ⁄6 ligand FSL-1 (Panel B). IFN-c
and TNF-a increased NCF1 expression (P < 0.05) and
superoxide production; nevertheless, it did not augment
the CYBB expression.
The TLR2 could trigger the expression of several genes
in monocytes ⁄macrophages and in polymorphonuclear cells
through a complex signalization network [15]. It is gener-
ally involved in immunological responses to gram-positive
bacteria [25, 26]. However, it is not known whether the
increment in TLR2 expression could contribute to increase
phagocyte activation against pathogen exposure.
We also explored the possibilities by which the BCG
could interfere with the NADPH system by analysing
the TLR2 gene expression of PBMC after incubation
with different BCG preparations, and FSL-1. As shown
in Fig. 2C, live BCG decreased the TLR2 gene expression
(P < 0.01), without interfering with cell viability as
assessed by tripan blue count.
It is well described in the literature that IL-10 has a
potent anti-inflammatory effect, able to prevent phago-
cyte activation. BCG also inhibits the MHC class II mol-
ecule expression on the surface of phagocytes by
inhibiting cathepsin S protein [6], a mechanism that is
IL-10 dependent [27].
To explore the possible effects of live, HK, or EFD
BCG, or FSL-1 on cytokine production by PBMC, we
evaluated the IL-10 and TNF-a release after incubation
protocols (Fig. 3). Live and HK BCG markedly increased
the TNF-a production (P < 0.001). On the other hand,
the increasing effect of EFD BCG on this cytokine was
85% lower than that induced by HK BCG (P < 0.001)
and 80% lower in relation to the live BCG effect
(P < 0.001) (Panel A). The live, HK and EFD BCG
increased IL-10 production (P < 0.001) (Panel B).
Discussion
The present work investigates the interaction between
BCG and human leucocytes; our hypothesis states that
there is an influence of live, HK or EFD BCG on the
human NADPH oxidase system and also TLR2 gene
expression as well as cytokine production using the
human PBMC model.
We observed that only live BCG inhibited superoxide
release. These data corroborate with other studies where
BCG and virulent strains of mycobacteria can evade the
microbicidal mechanism of phagocytes. One mechanism
of evasion is the inhibition of phagosome and lysosome
fusion, involving TACO protein and its analogous coro-
nin-1 in human leucocytes [12, 13]. These results are
particularly interesting once, Bustamante et al., our group
included [28] have recently identified mutations on
CYBB that are associated with mendelian susceptibility
to mycobacterial disease (MSMD), demonstrating that the
respiratory burst in human macrophages is a crucial
mechanism against tuberculous mycobacteria.
In vitro research showed that BCG is able to increase
the TLR2 gene expression in human uroepithelial and
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Figure 3 TNF-a (Panel A) and IL-10 (Panel B) release by peripheral
blood mononuclear cell. 5 · 105 cells ⁄ml were incubated in the absence
(control group – C) or presence of live, heat-killed, extended freeze-dry-
ing bacillus Calmette–Gue´rin or FSL-1 for 24 h. The results are shown
as pg ⁄ml of the respective cytokine. Statistically significant differences
between groups are indicated by their Kruskal–Wallis followed by
Dunn’s test P-values, n = at least 8.
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bladder cancer cells [29–32]. Some studies demonstrate
that TLR2 activation by bacterial lipoproteins can acti-
vate nuclear factor kappa jB (NF-jB) and initiate the
production of reactive oxygen intermediates by the THP-
1 lineage [33, 34].
One recent work of our group showed that CYBB and
NCF1 gene expression and the consequent superoxide
release are dependent on NF-jB action [35]. It is well
known that TLR2 participates on NF-jB activation path-
way and that BCG wall contains diverse lipoproteins that
are able to bind it [36].
We verified that live BCG was able to inhibit the
TLR2 expression, while inactivated HK and EFD BCG
and FSL-1 did not. These results together with the
increasing on CYBB gene expression by PBMC because
of the FSL-1 stimulus corroborate with the findings of
Luengo-Blanco et al. [35]. It is likely that inhibition of
TLR2 gene expression by live BCG decreases the avail-
ability of this receptor on PBMC membrane surface lead-
ing to impairment of NF-jB activation, contributing to
lower gene expression of CYBB and NCF1 which was
followed by a reduction in NADPH oxidase activity mea-
sured by superoxide release.
Live BCG was capable to stimulate TNF-a and IL-10
cytokine production. The elevated levels of IL-10 showed
in our results could contribute to the inhibitory effects
on the NADPH oxidase and TLR2 gene expression, dem-
onstrating that this cytokine can down regulate signal-
ling activation. Simas et al. [37] reported similar results
about TNF-a cytokine production by live BCG. Note-
worthy, we did not observe any significant difference in
cell-death patterns among our studied groups.
The levels of TNF-a and IL-10 in the supernatant of
PBMC exposed to HK BCG were similar to those stimu-
lated by live BCG, demonstrating that the BCG heat
killing process can alter the inhibitory effect of BCG over
the NADPH oxidase and TLR2 gene expression, how-
ever, without alteration of its capacity to induce cyto-
kines production.
Studies based on animal models have demonstrated
that EFD BCG is able to control and in some cases
reverse allergic inflammation, for example, decreasing
eosinophilia, preventing bronchial hyperreactivity and the
increase in fibronectin in airway lumen, confirming the
anti-inflammatory properties of the preparation [21, 22].
Our results corroborate with those obtained about EFD
BCG from murine models of asthma and are presented
here for the first time in human PBMC. This preparation
does not affect the NADPH oxidase system neither the
TLR2 gene expression on human PBMC. Moreover,
PBMC incubated with EFD BCG had augmented IL-10
and did not show alteration of TNF-a production. This
pattern of effects could be interesting in asthma treat-
ment potentially favouring the control of inflammation
in asthmatic lungs.
The inhibition of NADPH oxidase activation at a
gene expression level, the decrease in TLR2 gene expres-
sion as well the great production of IL-10 induced by
viable BCG showed in our results, may represent novel
mechanisms by which live BCG can jeopardize its demise
and evade the human immunological system.
This is the first work to illustrate that live and differ-
ent inactivate forms of BCG induce diverse responses on
NADPH oxidase system activation, TLR2 gene expres-
sion and IL-10 cytokine production by human leucocytes
in vitro.
Future work investigating signalling pathways and
other BCG strains is necessary to clarify our understand-
ing on how live and inactivate BCG preparations exert
their influences. Studies involving live or HK BCG Pas-
teur strain 1173P2 and EFD BCG Moreau strain will
also be important.
Acknowledgment
This work was supported by CNPq (Conselho Nacional
de Desenvolvimento Cientı´fico e Tecnolo´gico) and FA-
PESP (Fundac¸a˜o de Amparo a` Pesquisa do Estado de Sa˜o
Paulo) grant 04 ⁄14522-0. The authors thank Professor
Boris Vargaftig for donating EFD BCG.
References
1 Black GF, Weir RE, Floyd S et al. BCG-induced increase in inter-
feron-gamma response to mycobacterial antigens and efficacy of
BCG vaccination in Malawi and the UK: two randomised controlled
studies. Lancet 2002;359:1393–401.
2 Verma I, Grover A. Antituberculous vaccine development: a per-
spective for the endemic world. Expert Rev Vaccines 2009;8:1547–53.
3 Noss EH, Pai RK, Sellati TJ et al. Toll-like receptor 2-dependent
inhibition of macrophage class II MHC expression and antigen pro-
cessing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immu-
nol 2001;167:910–8.
4 Pai RK, Pennini ME, Tobian AA, Canaday DH, Boom WH, Har-
ding CV. Prolonged toll-like receptor signaling by Mycobacterium
tuberculosis and its 19-kilodalton lipoprotein inhibits gamma inter-
feron-induced regulation of selected genes in macrophages. Infect
Immun 2004;72:6603–14.
5 Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH.
Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand
that inhibits human macrophage class II MHC antigen processing.
J Immunol 2004;173:2660–8.
6 Sendide K, Deghmane AE, Pechkovsky D, Av-Gay Y, Talal A,
Hmama Z. Mycobacterium bovis BCG attenuates surface expression of
mature class II molecules through IL-10-dependent inhibition of
cathepsin S. J Immunol 2005;175:5324–32.
7 Pecora ND, Gehring AJ, Canaday DH, Boom WH, Harding CV.
Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that
regulates innate immunity and APC function. J Immunol
2006;177:422–9.
8 Wayne SJ, Rhyne RL, Garry PJ, Goodwin JS. Cell-mediated immu-
nity as a predictor of morbidity and mortality in subjects over 60.
J Gerontol 1990;45:M45–8.
9 Madura Larsen J, Benn CS, Fillie Y, van der Kleij D, Aaby P,
Yazdanbakhsh M. BCG stimulated dendritic cells induce an inter-
100 Human Leucocytes Response to Live, EFD or HK BCG J. Moreira et al.
..................................................................................................................................................................
 2011 The Authors
Scandinavian Journal of Immunology  2011 Blackwell Publishing Ltd. Scandinavian Journal of Immunology 75, 96–101
leukin-10 producing T-cell population with no T helper 1 or T
helper 2 bias in vitro. Immunology 2007;121:276–82.
10 Nauseef WM. Assembly of the phagocyte NADPH oxidase. Histo-
chem Cell Biol 2004;122:277–91.
11 McCaffrey RL, Allen L-AH. Pivotal advance: Francisella tularensis
LVS evades killing by human neutrophils via inhibition of the
respiratory burst and phagosome escape. J Leukoc Biol 2006;
80:1224–30.
12 Yan M, Di Ciano-Oliveira C, Grinstein S, Trimble WS. Coronin
function is required for chemotaxis and phagocytosis in human neu-
trophils. J Immunol 2007;178:5769–78.
13 Deghmane AE, Soulhine H, Bach H et al. Lipoamide dehydrogenase
mediates retention of coronin-1 on BCG vacuoles, leading to arrest
in phagosome maturation. J Cell Sci 2007;120:2796–806.
14 Quesniaux VJ, Nicolle DM, Torres D et al. Toll-like receptor 2
(TLR2)-dependent-positive and TLR2-independentnegative regula-
tion of proinflammatory cytokines by mycobacterial lipomannans.
J Immunol 2004;172:4425–34.
15 Lasker MV, Nair SK. Intracellular TLR signaling: a structural per-
spective on human disease. J Immunol 2006;177:11–6.
16 Yang CS, Shin DM, Lee HM et al. ASK1-p38 MAPK-p47phox acti-
vation is essential for inflammatory responses during tuberculosis
via TLR2-ROS signalling. Cell Microbiol 2008;10:741–54.
17 Nathan C. Specificity of a third kind: reactive oxygen and nitrogen
intermediates in cell signaling. J Clin Invest 2003;111:769–78.
18 Rhee SG, Chang TS, Bae YS, Lee SR, Kang SW. Cellular regulation
by hydrogen peroxide. J Am Soc Nephrol 2003;14:S211–5.
19 Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E.
Involvement of reactive oxygen species in Toll-like receptor 4-
dependent activation of NF-kappa B. J Immunol 2004;172:2522–9.
20 Petricevich VL, Ueda C, Alves RC et al. A single strain of Mycobac-
terium bovis bacillus Calmette–Gue´rin (BCG) grown in two different
media evokes distinct humoral immune responses in mice. Braz
J Med Biol Res 2001;34:81–92.
21 Hubeau C, Singer M, Lagranderie M, Marchal G, Vargaftig B.
Extended freeze-dried Mycobacterium bovis bacillus Calmette–Gue´rin
induces the release of interleukin-12 but not tumor necrosis factor-a
by alveolar macrophages, both in vitro and in vivo. Clin Exp Allergy
2003;33:386–93.
22 Lagranderie M, Abolhassani M, Vanoirbeek J et al. Mycobacterium
bovis BCG killed by extended freeze-drying reduces airway hyperre-
sponsiveness in 2 animal models. J Allergy Clin Immunol
2008;121:471–8.
23 Condino-Neto A, Newburger PE. Interferon-gamma improves splic-
ing efficiency of CYBB gene transcripts in an interferon-responsive
variant of chronic granulomatous disease due to a splice site consen-
sus region mutation. Blood 2000;95:3548–54.
24 Condino-Neto A, Newburger PE. NADPH oxidase activity and
cytochrome b558 content of human Epstein–Barr-virus-transformed
B lymphocytes correlate with expression of genes encoding compo-
nents of the oxidase system. Arch Biochem Biophys 1998;360:158–64.
25 Muzio M, Bosisio D, Polentarutti N et al. Differential expression
and regulation of toll-like receptors (TLR) in human leukocytes:
selective expression of TLR3 in dendritic cells. J Immunol
2000;164:5998–6004.
26 Zarember KA, Godowski PJ. Tissue expression of human Toll-like
receptors and differential regulation of Toll-like receptor mRNAs in
leukocytes in response to microbes, their products, and cytokines.
J Immunol 2002;168:554–61.
27 Soualhine H, Deghmane AE, Sun J et al. Mycobacterium bovis bacillus
Calmette–Gue´rin secreting active cathepsin S stimulates expression
of mature MHC class II molecules and antigen presentation in
human macrophages. J Immunol 2007;179:5137–45.
28 Bustamante J, Arias AA, Vogt G et al. Germline CYBB mutations
that selectively affect macrophages in kindreds with X-linked pre-
disposition to tuberculous mycobacterial disease. Nat Immunol
2011;12:213–21.
29 Tsuji S, Matsumoto M, Takeuchi O et al. Maturation of human
dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus
Calmette–Gue´rin: involvement of toll-like receptors. Infect Immun
2000;68:6883–90.
30 Li X, Gong ZY, Li H, Wei Q, Shi M, Yang YR. Study on Toll-
like receptors expression and cytokine production induced by bacil-
lus Calmette–Gue´rin in human bladder cancer cell. Zhonghua Wai
Ke Za Zhi 2004;42:177–81.
31 Li X, Gong ZY, Shi M, Wei Q, Li H, Yang YR. Study on the
inducible expression of toll-like receptors in human bladder cell
line. Sichuan Da Xue Xue Bao Yi Xue Ban 2004;35:340–2.
32 Miyazaki J, Kawai K, Oikawa T et al. Uroepithelial cells can
directly respond to Mycobacterium bovis bacillus Calmette–Gue´rin
through Toll-like receptor signalling. BJU Int 2006;97:860–4.
33 Aliprantis AO, Yang RB, Mark MR et al. Cell activation and apop-
tosis by bacterial lipoproteins through toll-like receptor-2. Science
1999;285:736–9.
34 Aliprantis AO, Weiss DS, Zychlinsky A. Toll-like receptor-2 trans-
duces signals for NF-kappa B activation, apoptosis and reactive oxy-
gen species production. J Endotoxin Res 2001;7:287–91.
35 Luengo-Blanco M, Prando C, Bustamante J et al. Essential role of
nuclear factor-kB for NADPH oxidase activity in normal and anhid-
rotic ectodermal dysplasia leukocytes. Blood 2008;112:1453–60.
36 Jo EK, Yang CS, Choi CH, Harding CV. Intracellular signalling
cascades regulating innate immune responses to Mycobacteria:
branching out from Toll-like receptors. Cell Microbiol 2007;9:1087–
98.
37 Simas CJ, Silva DP, Ponte CG, Castello-Branco LR, Antas PR. Pat-
terns of in vitro cell-death, metaloproteinase-9 and pro-inflamma-
tory cytokines in human monocytes induced by the BCG vaccine,
Moreau strain. Vaccine 2011;29:6446–50.
J. Moreira et al. Human Leucocytes Response to Live, EFD or HK BCG 101
..................................................................................................................................................................
 2011 The Authors
Scandinavian Journal of Immunology  2011 Blackwell Publishing Ltd. Scandinavian Journal of Immunology 75, 96–101
